IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,879,179 | -7.3% | 195,138 | +2.4% | 0.00% | 0.0% |
| Q2 2023 | $2,027,208 | +35.3% | 190,527 | +33.8% | 0.00% | – |
| Q1 2023 | $1,498,573 | +27.5% | 142,450 | +50.1% | 0.00% | – |
| Q4 2022 | $1,175,799 | +10.9% | 94,899 | -7.3% | 0.00% | – |
| Q3 2022 | $1,060,000 | -62.3% | 102,337 | -58.0% | 0.00% | -100.0% |
| Q2 2022 | $2,812,000 | -59.3% | 243,867 | -55.6% | 0.00% | -50.0% |
| Q1 2022 | $6,903,000 | -0.0% | 548,781 | -7.3% | 0.00% | 0.0% |
| Q4 2021 | $6,905,000 | -59.2% | 592,200 | -54.3% | 0.00% | -50.0% |
| Q3 2021 | $16,939,000 | +37.0% | 1,297,039 | +35.0% | 0.00% | +33.3% |
| Q2 2021 | $12,362,000 | +100.0% | 960,526 | +73.8% | 0.00% | +200.0% |
| Q1 2021 | $6,180,000 | +33.9% | 552,701 | +36.4% | 0.00% | 0.0% |
| Q4 2020 | $4,615,000 | +17.5% | 405,145 | -7.2% | 0.00% | 0.0% |
| Q3 2020 | $3,928,000 | -14.7% | 436,674 | -2.1% | 0.00% | 0.0% |
| Q2 2020 | $4,603,000 | +37.2% | 445,967 | +34.1% | 0.00% | 0.0% |
| Q1 2020 | $3,356,000 | -25.1% | 332,603 | -1.2% | 0.00% | 0.0% |
| Q4 2019 | $4,482,000 | +76.2% | 336,712 | +13.6% | 0.00% | 0.0% |
| Q3 2019 | $2,544,000 | -15.8% | 296,351 | +7.3% | 0.00% | 0.0% |
| Q2 2019 | $3,021,000 | -25.3% | 276,076 | -7.6% | 0.00% | 0.0% |
| Q1 2019 | $4,043,000 | +54.6% | 298,754 | +18.4% | 0.00% | 0.0% |
| Q4 2018 | $2,615,000 | +77.9% | 252,384 | +217.0% | 0.00% | – |
| Q3 2018 | $1,470,000 | -15.5% | 79,626 | -12.5% | 0.00% | -100.0% |
| Q2 2018 | $1,740,000 | -48.8% | 91,021 | -58.6% | 0.00% | 0.0% |
| Q1 2018 | $3,397,000 | +9.9% | 220,113 | +6.8% | 0.00% | 0.0% |
| Q4 2017 | $3,091,000 | +15.5% | 206,186 | +0.3% | 0.00% | 0.0% |
| Q3 2017 | $2,676,000 | +35.8% | 205,543 | +96.9% | 0.00% | 0.0% |
| Q2 2017 | $1,970,000 | +20.0% | 104,403 | +8.5% | 0.00% | 0.0% |
| Q1 2017 | $1,642,000 | +11.9% | 96,263 | +0.3% | 0.00% | 0.0% |
| Q4 2016 | $1,468,000 | +76.0% | 96,022 | +82.9% | 0.00% | – |
| Q3 2016 | $834,000 | +23.2% | 52,487 | +1.5% | 0.00% | – |
| Q2 2016 | $677,000 | +14.9% | 51,733 | -3.9% | 0.00% | – |
| Q1 2016 | $589,000 | +4.8% | 53,835 | +11.1% | 0.00% | – |
| Q4 2015 | $562,000 | +35.1% | 48,463 | +21.7% | 0.00% | – |
| Q3 2015 | $416,000 | -76.0% | 39,824 | -72.3% | 0.00% | -100.0% |
| Q2 2015 | $1,734,000 | -58.4% | 143,871 | -44.7% | 0.00% | 0.0% |
| Q1 2015 | $4,164,000 | +78.3% | 260,252 | +70.7% | 0.00% | 0.0% |
| Q4 2014 | $2,335,000 | +30.4% | 152,443 | +10.4% | 0.00% | 0.0% |
| Q3 2014 | $1,790,000 | +104.3% | 138,127 | +141.6% | 0.00% | – |
| Q2 2014 | $876,000 | +13.0% | 57,166 | -9.1% | 0.00% | – |
| Q1 2014 | $775,000 | -84.7% | 62,905 | -85.6% | 0.00% | -100.0% |
| Q4 2013 | $5,055,000 | +422.8% | 435,493 | +433.1% | 0.00% | – |
| Q3 2013 | $967,000 | +21.3% | 81,693 | +1.7% | 0.00% | – |
| Q2 2013 | $797,000 | – | 80,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |